Cite Filings / AVTX / 9999999995-23-001063

Feed Companies Filings Check

Sign in

EFFECT

Notice of Effectiveness

Avalo Therapeutics, Inc. Filed 2023-04-27 Acc 9999999995-23-001063

Documents 1

EFFECT Notice of Effectiveness , xslEFFECTX01/primary_doc.xml

Around this filing

2023-05-02 EFFECT Notice of Effectiveness
2023-04-28 CORRESP Correspondence Between Filers and SEC Staff
2023-04-27 EFFECT Notice of Effectiveness
2023-04-27 4 Changes in Ownership
2023-04-25 POS AM Post-effective Amendment for Registration Statement
2023-04-24 4 Changes in Ownership
2021-03-19 EFFECT Notice of Effectiveness

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslEFFECTX01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…